Why the study?
Patients with rheumatic diseases have structural and functional changes and require constant medications, leading to an increased risk of intraoperative and postoperative complications.
This review summarizes current recommendations for the perioperative management of antirheumatic drugs, including DMARDs, biologics, and glucocorticoids, to minimize surgical complications in patients with rheumatic diseases.
May aid peri-op caution in rheumatic patients; leaves open validation of current recommendations.
The rheumatic patients are characterized by various structural and functional changes, caused by chronic disease the necessity of constant medication intake, including anti-inflammatory drugs and immunosuppressants. In this regard, the rheumatic patients have an increased risk of intraoperative and postoperative complications. The purpose of this publication is to review current recommendations on the topic of perioperative management of rheumatic patients. The publication consists of two parts. In the first part we review the issues of perioperative administration of steroids, disease-modifying antirheumatic drugs, biologics and nonsteroidal anti-inflammatory drugs.
No takes yet. Share an insight, caveat, or question.
Lyalina et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: